Get the Weekly Intelligence Brief — top committee picks every Sunday.

CORT vs GMED

Corcept Therapeutics Incorporated vs Globus Medical — AI-powered side-by-side comparison
CORT
Corcept Therapeutics Incorporated
56
Watch
VS
GMED
Globus Medical
71
Buy
MetricCORTGMED
AI Score 56 71
Price $111.83 $85.12
P/E Ratio 215.12× 21.45×
ROE 15.4% 11.8%
Revenue Growth YoY
Gross Margin 98.3% 68.5%
Debt / Equity 0.01× 0.02×
Dividend Yield 0.0% 0.0%
RSI (14) 61.4 75.9
Beta 0.455 0.954
Expected Upside +0.1%

AI Committee View

Current Innellis committee reasoning for CORT versus GMED.
GMED leads by 15 points.

GMED scores 71/100 (Buy) versus CORT at 56/100 (Watch).

CORT Committee View
67% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Value Analyst remains cautious — p/e of 223.5 is expensive by classic value standards. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
  • P/E of 223.5 is expensive by classic value standards — Value
  • Price-to-book of 11.4x prices in significant intangible value — Value
  • EPS declining -62.5% YoY despite any revenue growth — Growth
GMED Committee View
75% agreement
4 analysts

The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is rsi at 76 is in overbought territory. The committee is constructive but not yet at full conviction.

Bull Case
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • RSI at 76 is in overbought territory — Technical
  • Price trading above the upper Bollinger Band -- stretched — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
CORT Full Analysis GMED Full Analysis